Benralizumab in Severe Eosinophilic Asthma: Toward Disease Control and Evolving Treatment Paradigms.

Fasenra (benralizumab) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42741441

Alessandro Vatrella; Angelantonio Maglio; Antonio Franzese; Carolina Vitale; Cecilia Calabrese; Corrado Pelaia; Girolamo Pelaia; Luisa Oriana D'Auria; Valeria Longobardi

Sep 16, 2026